Cargando…
Age independent survival benefit for patients with small hepatocellular carcinoma undergoing percutaneous cryoablation: A propensity scores matching study
BACKGROUND: Hepatocellular carcinoma (HCC) is the major cause of malignancy-related deaths worldwide, and its incidence is likely to increase in the future as life expectancy increases. Therefore, the management of elderly patients with HCC has become a global issue. Aim of this study was to assess...
Autores principales: | Zhang, Huixin, Xu, Muoyan, Shao, Jiashen, Kong, Huifang, Gao, Xudong, Zhang, Wei, Chang, Xiujuan, Yang, Bin, Chen, Yan, Dong, Zheng, Huang, Jiagan, Zeng, Zhen, Yang, Yongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895933/ https://www.ncbi.nlm.nih.gov/pubmed/36741016 http://dx.doi.org/10.3389/fonc.2023.1072054 |
Ejemplares similares
-
Percutaneous Argon-Helium Cryoablation for Small Hepatocellular Carcinoma Located Adjacent to a Major Organ or Viscus: A Retrospective Study of 92 Patients at a Single Center
por: Zhang, Wei, et al.
Publicado: (2021) -
Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma
por: Yang, Yongping, et al.
Publicado: (2011) -
Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria
por: Rong, Guanghua, et al.
Publicado: (2015) -
MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents
por: Yang, Bin, et al.
Publicado: (2019) -
Percutaneous Cryoablation for Liver Cancer
por: Niu, Li-Zhi, et al.
Publicado: (2014)